Page All:
Page 1
Usability Sciences Corporation Launches WebIQ Pharma - An Intelligent Survey Tool That Allows Pharma Sites to Measure and Improve Website Effectiveness
IRVING, Texas, March 23 -- Usability Sciences Corporation launches its WebIQ Pharma offering, an intelligent survey solution that provides pharmaceutical sites with metrics to answer critical questions about site and content effectiveness, to increase return on investment (ROI). Usability Sciences has provided usability and user experience research to Merck (MRK), Eli Lilly (LLY), Novartis (NVS) and Ortho McNeil for over ten years.
Pharmaceutical brands build websites primarily to drive drug adoption. The brands want site visitors who have never tried the drug to make appointments with their doctors to discuss the drug. The brands want visitors who have been prescribed the drug to keep taking it and get their prescriptions refilled. Most importantly, the brands need to know which content areas drive the desired behaviors and which content areas do not. Establishing the link between visitor response to the site and the content that determined their response has heretofore been extremely difficult. WebIQ Pharma makes it simple and, compared to the labor-intensive alternatives, extremely cost effective.
"WebIQ Pharma employs intelligent survey technology and intelligent dashboards in delivering this patented solution," said Usability Sciences President Jeff Schueler. "The intelligent survey technology allows the brand to ask questions of site visitors based on where they went on the site and what content they saw. WebIQ Pharma dashboards, rather than deliver more 'dumb' data, provide answers to the site's key business questions."
Usability Sciences developed the methodology specifically for the pharmaceutical industry, where brand sites often carry high costs but generate relatively low traffic. WebIQ Pharma arms the brand with a continuous stream of answers to drug adoption questions and allows them to constantly improve site stickiness, conversion, and ROI. WebIQ Pharma is flexible and can be customized to fit any brand's needs and preferences in terms of options and pricing.
More information can be found at http://www.usabilitysciences.com/solutions/webiq/webiq-pharma or by contacting the company directly at info@usabilitysciences.com.
About Usability Sciences:
With more than 20 years of experience in the usability and user experience arena, Usability Sciences has developed an industry-leading portfolio of research methodologies that delivers robust and actionable results to its Fortune 500 client base. For more information about Usability Sciences' service offerings, go to http://www.usabilitysciences.com or call 1-800-820-1222.
Press Release Contact Information:
Jeff Schueler
Media Liaison
Usability Sciences Corporation
(972) 550-1599
jschueler@usabilitysciences.com
This release was issued through WebWire(R). For more information visit http://www.webwire.com/.
Source: Usability Sciences Corporation
CONTACT: Jeff Schueler, Media Liaison, Usability Sciences Corporation,
+1-972-550-1599, jschueler@usabilitysciences.com
Web Site: http://www.usabilitysciences.com/
Usability Sciences Corporation Launches WebIQ Pharma - An Intelligent Survey Tool That Allows Pharma Sites to Measure and Improve Website Effectiveness
IRVING, Texas, March 23 -- Usability Sciences Corporation launches its WebIQ Pharma offering, an intelligent survey solution that provides pharmaceutical sites with metrics to answer critical questions about site and content effectiveness, to increase return on investment (ROI). Usability Sciences has provided usability and user experience research to Merck (MRK), Eli Lilly (LLY), Novartis (NVS) and Ortho McNeil for over ten years.
Pharmaceutical brands build websites primarily to drive drug adoption. The brands want site visitors who have never tried the drug to make appointments with their doctors to discuss the drug. The brands want visitors who have been prescribed the drug to keep taking it and get their prescriptions refilled. Most importantly, the brands need to know which content areas drive the desired behaviors and which content areas do not. Establishing the link between visitor response to the site and the content that determined their response has heretofore been extremely difficult. WebIQ Pharma makes it simple and, compared to the labor-intensive alternatives, extremely cost effective.
"WebIQ Pharma employs intelligent survey technology and intelligent dashboards in delivering this patented solution," said Usability Sciences President Jeff Schueler. "The intelligent survey technology allows the brand to ask questions of site visitors based on where they went on the site and what content they saw. WebIQ Pharma dashboards, rather than deliver more 'dumb' data, provide answers to the site's key business questions."
Usability Sciences developed the methodology specifically for the pharmaceutical industry, where brand sites often carry high costs but generate relatively low traffic. WebIQ Pharma arms the brand with a continuous stream of answers to drug adoption questions and allows them to constantly improve site stickiness, conversion, and ROI. WebIQ Pharma is flexible and can be customized to fit any brand's needs and preferences in terms of options and pricing.
More information can be found at http://www.usabilitysciences.com/solutions/webiq/webiq-pharma or by contacting the company directly at info@usabilitysciences.com.
About Usability Sciences:
With more than 20 years of experience in the usability and user experience arena, Usability Sciences has developed an industry-leading portfolio of research methodologies that delivers robust and actionable results to its Fortune 500 client base. For more information about Usability Sciences' service offerings, go to http://www.usabilitysciences.com or call 1-800-820-1222.
Press Release Contact Information:
Jeff Schueler
Media Liaison
Usability Sciences Corporation
(972) 550-1599
jschueler@usabilitysciences.com
This release was issued through WebWire(R). For more information visit http://www.webwire.com/.
Source: Usability Sciences Corporation
CONTACT: Jeff Schueler, Media Liaison, Usability Sciences Corporation,
+1-972-550-1599, jschueler@usabilitysciences.com
Web Site: http://www.usabilitysciences.com/